Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Receivables (2020 - 2025)

iSpecimen has reported Change in Receivables over the past 6 years, most recently at -$26827.0 for Q4 2025.

  • Quarterly results put Change in Receivables at -$26827.0 for Q4 2025, down 105.94% from a year ago — trailing twelve months through Dec 2025 was -$1.3 million (down 247.95% YoY), and the annual figure for FY2025 was -$1.3 million, down 247.95%.
  • Change in Receivables for Q4 2025 was -$26827.0 at iSpecimen, up from -$255059.0 in the prior quarter.
  • Over the last five years, Change in Receivables for ISPC hit a ceiling of $1.6 million in Q1 2023 and a floor of -$1.4 million in Q2 2023.
  • Median Change in Receivables over the past 5 years was -$59933.5 (2024), compared with a mean of -$32922.8.
  • Biggest five-year swings in Change in Receivables: surged 431.65% in 2021 and later tumbled 708.19% in 2025.
  • iSpecimen's Change in Receivables stood at $410978.0 in 2021, then tumbled by 311.73% to -$870148.0 in 2022, then dropped by 5.19% to -$915269.0 in 2023, then surged by 149.34% to $451570.0 in 2024, then plummeted by 105.94% to -$26827.0 in 2025.
  • The last three reported values for Change in Receivables were -$26827.0 (Q4 2025), -$255059.0 (Q3 2025), and -$302646.0 (Q2 2025) per Business Quant data.